Generic statin options can save the US $11.9B per year

The end of market exclusivity for statin medications is associated with substantial cost savings, according to new data published in JAMA Network Open. “Generic competition is effective for reducing prescription prices in the United States,” co-authors Hong Xue, PhD, and Shuo-yu Lin from…

Read the full article here

Related Articles